First Tracks Biotherapeutics Inc
TRAX Market Cap, Stock Price & Valuation
With a market capitalization (market cap) of $1.23B — a measure of how much the company is worth — First Tracks Biotherapeutics Inc is the 2423rd most valuable company in Healthcare as of July 10, 2026. Shares trade at $35.31, up +8.99% on the day.
$35.31
+8.99%gain today
Market position
Market cap rank
#2423
of 2,595
1-day
+8.99%
1-month
+114.26%
6-month
—
YTD
—
1-year
—
5-year
—
Key figures
Market cap
$1.23B
P/E (live)
—
price ÷ annual EPS
P/E (reported)
0.0
FY 2025
EPS
$0.00
FY 2025
Dividend yield
0.00%
FY 2025
Dividend / share
$0.00
Gross margin
0.00%
FY 2025
Operating margin
0.00%
FY 2025
Net margin
0.00%
FY 2025
Return on equity
—
FY 2025
Valuation & financial health
Enterprise value
$-224.08M
FY 2025
EV / EBITDA
1.26
FY 2025
EV / Sales
0.00
FY 2025
Price / book
0.00
FY 2025
Price / sales
0.00
FY 2025
Earnings yield
0.00%
FY 2025
FCF yield
0.00%
FY 2025
Debt / equity
0.05
FY 2025
Current ratio
10.20
FY 2025
Return on assets
—
FY 2025
Return on invested capital
Financials · FY 2025
Revenue
$0
Gross profit
$-139.61M
Operating income
$-179.01M
EBITDA
$-178.45M
Net income
$-166.09M
Diluted EPS
$0.00
Shares outstanding
0
Trading
Open
$33.01
Previous close
$32.40
Day range
$33.01 – $38.49
52-week range
$14.72 – $38.49
50-day avg
$18.39
200-day avg
$19.07
Volume
1,115,548
Avg volume
528,242
Beta
0.00
Price history
Compare with peers
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Visit websiteCompany info
CEO
Daniel R. Faga
IPO date
Apr 20, 2026
Headquarters
San Diego, CA, US
Country
US
Frequently asked questions
How much is First Tracks Biotherapeutics Inc worth?
As of July 10, 2026, First Tracks Biotherapeutics Inc (TRAX) is worth $1.23B — this is its market capitalization, the total value of all its outstanding shares.
What is First Tracks Biotherapeutics Inc’s market cap?
First Tracks Biotherapeutics Inc’s market cap is $1.23B, which ranks it #2423 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
What is First Tracks Biotherapeutics Inc’s stock price?
First Tracks Biotherapeutics Inc (TRAX) shares trade at $35.31, up 8.99% on the day, as of July 10, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
